scispace - formally typeset
E

Ewart Thomas Cole

Researcher at Capsugel

Publications -  19
Citations -  1500

Ewart Thomas Cole is an academic researcher from Capsugel. The author has contributed to research in topics: Dosage form & Gelatin. The author has an hindex of 14, co-authored 19 publications receiving 1434 citations. Previous affiliations of Ewart Thomas Cole include Pfizer.

Papers
More filters
Journal ArticleDOI

Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration

TL;DR: Filling and sealing technologies for hard capsules, provides the formulator with the flexibility of developing formulations in-house from small scale, as required for Phase I studies, up to production.
Journal ArticleDOI

Enteric coated HPMC capsules designed to achieve intestinal targeting

TL;DR: The product visualisation technique of gamma scintigraphy was used to establish the in vivo disintegration properties of HPMC units coated with Eudragit L 30 D-55, and complete disintegration occurred predominately in the small bowel in an average time of 2.4 h post dose.
Journal ArticleDOI

Evaluation of hot-melt extrusion as a new technique for the production of polymer-based pellets for sustained release capsules containing high loadings of freely soluble drugs

TL;DR: In this paper, hot-melt screw extrusion was presented as an alternative method for producing polymer-based sustained release (SFL) pellets, which were produced with diltiazem hydrochloride as model drug.
Journal ArticleDOI

Various ways of modulating the release of diltiazem hydrochloride from hot-melt extruded sustained release pellets prepared using polymeric materials

TL;DR: In this paper, the authors used a double exponential decay equation to discriminate between surface release and diffusion-controlled release phases for diltiazem hydrochloride, and then optimized the release profile of the drug to achieve therapeutic plasma levels with a once or twice daily administration.
Journal ArticleDOI

Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25 mg atenolol

TL;DR: It was showed that it was not possible to increase the bioavailability of a poorly absorbed drug such as atenolol using gastroretentive formulations and the maximum plasma concentration was diminished.